197 related articles for article (PubMed ID: 11979748)
41. Serum soluble interleukin 2 receptor alpha and soluble CD8 levels in patients with gynecological malignancies undergoing radiotherapy.
Frydecka I; Rusiecka M; Kuliczkowski K; Kornafel J
Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):123-6. PubMed ID: 8915516
[TBL] [Abstract][Full Text] [Related]
42. The level of interleukin-2 and of soluble interleukin-2 receptor in patients with Balkan nephropathy.
Vöö S; Drugărin D; Mărgineanu F; Koreck A; Negru S; Biriescu A
Roum Arch Microbiol Immunol; 2002; 61(3):207-16. PubMed ID: 14752984
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of serum soluble interleukin-2 receptor level in non-Hodgkin's lymphoma: a single center study in Japan.
Kono N; Kanda Y; Yamamoto R; Chizuka A; Suguro M; Hamaki T; Arai C; Matsuyama T; Takezako N; Miwa A; Togawa A
Leuk Lymphoma; 2000 Mar; 37(1-2):151-6. PubMed ID: 10721779
[TBL] [Abstract][Full Text] [Related]
44. Levels of interferon-gamma and interleukin-2 receptor-alpha for bronchoalveolar lavage fluid and serum were correlated with clinical grade and treatment of pulmonary tuberculosis.
Tsao TC; Huang CC; Chiou WK; Yang PY; Hsieh MJ; Tsao KC
Int J Tuberc Lung Dis; 2002 Aug; 6(8):720-7. PubMed ID: 12150485
[TBL] [Abstract][Full Text] [Related]
45. [Soluble interleukin-2 receptor and macrophage colony-stimulating factor (M-CSF) in cerebrospinal fluid in patients with hematological malignancies: clinical significance in adult T-cell leukemia with meningeal infiltration].
Tanaka K; Shiraishi K; Sakamoto A; Fukahori S; Jojima H; Osabe S; Mizunoe K; Masuchi K; Imamura Y; Honda J; Egami K; Natori H; Oizumi K
Rinsho Ketsueki; 1996 Jul; 37(7):610-7. PubMed ID: 8779781
[TBL] [Abstract][Full Text] [Related]
46. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
47. [The changes of soluble interleukin-2 receptor in serum and cerebrospinal fluid of patients with delayed encephalopathy after acute carbon monoxide poisoning].
Gu R; Zhang X; Lu L; Lu H; Song J; Guo X; Zhang Z; Liu M
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2002 Oct; 20(5):350-2. PubMed ID: 14694723
[TBL] [Abstract][Full Text] [Related]
48. Circulating soluble interleukin-2 receptor level predicts remission in very early reactive arthritis.
Kuuliala A; Söderlin M; Kautiainen H; Repo H; Leirisalo-Repo M
Scand J Rheumatol; 2005; 34(5):372-5. PubMed ID: 16234184
[TBL] [Abstract][Full Text] [Related]
49. [Level and significance of the soluble interleukin-2 receptor expression in serum of patients with bladder cancer].
Wen R; Xie S; Ma P
Zhonghua Wai Ke Za Zhi; 1996 Jan; 34(1):16-8. PubMed ID: 9275680
[TBL] [Abstract][Full Text] [Related]
50. Serum evaluation of the balance between soluble interleukin-2 and interleukin-4 receptors.
Fujita N; Okamoto Y; Gotoh Y; Yada Y; Suzuki Y; Ando T; Togari H; Nishida M
Cytokine; 2005 Nov; 32(3-4):143-8. PubMed ID: 16226465
[TBL] [Abstract][Full Text] [Related]
51. [Diagnostic value of serum soluble interleukin-2 receptor levels in interstitial pneumonia of the patients with hematological disorders].
Kohda K; Koike K; Matsumoto S; Kida M; Nakazawa O; Nagamachi Y; Mizushima S
Rinsho Ketsueki; 1997 Feb; 38(2):146-8. PubMed ID: 9059070
[TBL] [Abstract][Full Text] [Related]
52. Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients.
Sirota P; Meiman M; Herschko R; Bessler H
Psychiatry Res; 2005 Apr; 134(2):151-9. PubMed ID: 15840416
[TBL] [Abstract][Full Text] [Related]
53. Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2Rα) in patients with non-Hodgkin's lymphoma.
Jo SA; Hwang SH; Chang CL; Kim SY; Shin HJ; Chung JS; Sol MY; Lee EY
Korean J Lab Med; 2010 Dec; 30(6):600-5. PubMed ID: 21157146
[TBL] [Abstract][Full Text] [Related]
54. [Studies on the relationship between the level of cytokine and liver function in patients with clonorchiasis sinensis].
Cai LS; Xiao JY; Xin H; Zhu LX; Chen G; Zhang T; Wang GZ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Feb; 22(1):54-6. PubMed ID: 15283270
[TBL] [Abstract][Full Text] [Related]
55. [Observation of soluble interleukin-2 receptor(sIL-2R) and tumor necrosis factor(TNF) in patients with malignant tumors of salivary gland].
Yang YH; Fu QH
Shanghai Kou Qiang Yi Xue; 1999 Jun; 8(2):80-1. PubMed ID: 15048274
[TBL] [Abstract][Full Text] [Related]
56. Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies.
Nakase K; Tsuji K; Tamaki S; Tanigawa M; Ikeda T; Miyanishi E; Shiku H
Cancer Detect Prev; 2005; 29(3):256-9. PubMed ID: 15899555
[TBL] [Abstract][Full Text] [Related]
57. Extracorporeal photochemotherapy in patients with cutaneous T-cell lymphoma: is clinical response predictable?
Rao V; Ryggen K; Aarhaug M; Dai HY; Jørstad S; Moen T
J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1100-7. PubMed ID: 16987266
[TBL] [Abstract][Full Text] [Related]
58. Clinical significance of sIL-2R levels in B-cell lymphomas.
Yoshida N; Oda M; Kuroda Y; Katayama Y; Okikawa Y; Masunari T; Fujiwara M; Nishisaka T; Sasaki N; Sadahira Y; Mihara K; Asaoku H; Matsui H; Seto M; Kimura A; Arihiro K; Sakai A
PLoS One; 2013; 8(11):e78730. PubMed ID: 24236041
[TBL] [Abstract][Full Text] [Related]
59. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
[TBL] [Abstract][Full Text] [Related]
60. [The value of measuring the serum level of soluble interleukin-2 receptors in lung cancer patients].
Siemińska A
Pol Merkur Lekarski; 2004 Feb; 16(92):188-90. PubMed ID: 15176308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
